<DOC>
	<DOCNO>NCT00443924</DOCNO>
	<brief_summary>The purpose trial evaluate safety tolerability INS115644 Ophthalmic Solution subject bilateral ocular hypertension early primary open angle glaucoma investigate intraocular pressure lower effect INS115644 Ophthalmic Solution .</brief_summary>
	<brief_title>Study INS115644 Ophthalmic Solution Subjects With Ocular Hypertension Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Have diagnosis bilateral ocular hypertension early primary open angle glaucoma Have best correct visual acuity eye least +0.5 well Have normal endothelial cell count morphology Are diagnose closed angle glaucoma , exfoliation syndrome exfoliation glaucoma , pigment dispersion secondary glaucoma Have history type intraocular surgery , except cataract surgery Have cataract surgery within three month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Bilateral ocular hypertension early primary open angle glaucoma</keyword>
</DOC>